Nu Skin Enterprises Files 10-Q for Q2 2024
Ticker: NUS · Form: 10-Q · Filed: 2024-08-09T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, debt
TL;DR
NU SKIN 10-Q FILED: Q2 2024 financials are in. Check for performance updates.
AI Summary
Nu Skin Enterprises, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates. Key financial figures and strategic initiatives are presented, reflecting the company's ongoing business activities and market position.
Why It Matters
This filing provides investors and analysts with a detailed look at Nu Skin's financial health and operational performance during the second quarter of 2024, influencing investment decisions.
Risk Assessment
Risk Level: medium — 10-Q filings are standard for public companies, but the specific financial details and any disclosed risks within this report could impact the company's stock.
Key Numbers
- 7.44% — Variable 30 day rate (Indicates a fluctuating interest rate, potentially impacting financing costs.)
- 21% — Principal amount payable in installments (Shows a portion of debt is being paid down over a five-year period starting September 30, 2022.)
Key Players & Entities
- NU SKIN ENTERPRISES, INC. (company) — Filer of the 10-Q
- GREGORY BELLISTON (person) — Contact person for business and mail address
- 20240630 (date) — End of the reporting period
- 20240809 (date) — Filing date
FAQ
What was Nu Skin's revenue for the second quarter of 2024?
The provided text does not contain specific revenue figures for Q2 2024.
What is the company's total debt as of June 30, 2024?
The filing does not explicitly state the total debt amount as of June 30, 2024, but mentions a principal amount with installment payments.
Are there any significant legal proceedings mentioned in the filing?
The provided text does not detail any specific legal proceedings.
What is the company's net income for the reported period?
Specific net income figures for the period ending June 30, 2024, are not present in the provided text.
What are the key risks highlighted by Nu Skin in this 10-Q?
The provided text does not list specific risks identified by Nu Skin in this filing.
From the Filing
0001140361-24-036467.txt : 20240809 0001140361-24-036467.hdr.sgml : 20240809 20240808205752 ACCESSION NUMBER: 0001140361-24-036467 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240809 DATE AS OF CHANGE: 20240808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NU SKIN ENTERPRISES, INC. CENTRAL INDEX KEY: 0001021561 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 870565309 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12421 FILM NUMBER: 241190146 BUSINESS ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 BUSINESS PHONE: 801-345-1000 MAIL ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ENTERPRISES INC DATE OF NAME CHANGE: 19980909 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC DATE OF NAME CHANGE: 19960919 10-Q 1 ef20029695_10q.htm 10-Q false 12-31 2024 Q2 0001021561 10700000 5800000 Variable 30 day: 7.44% Variable 30 day: 7.44% 21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end of the five-year term. 2024-02 2024-05 2024-08 0001021561 2024-01-01 2024-06-30 0001021561 2024-08-01 0001021561 2023-12-31 0001021561 2024-06-30 0001021561 2023-01-01 2023-06-30 0001021561 2023-04-01 2023-06-30 0001021561 2024-04-01 2024-06-30 0001021561 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001021561 us-gaap:RetainedEarningsMember 2023-03-31 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2022-12-31 0001021561 2022-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2023-03-31 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001021561 2024-03-31 0001021561 us-gaap:RetainedEarningsMember 2023-12-31 0001021561 us-gaap:RetainedEarningsMember 2022-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2023-12-31 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-03-31 0001021561 us-gaap:TreasuryStockCommonMember 2024-03-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001021561 2023-03-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001021561 us-gaap:RetainedEarningsMember 2024-03-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001021561 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001021561 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001021561 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-01-01 2024-06-30 0001021561 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0001021561 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-06-30 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001021561 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0001021561 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001021561 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001021561 us-gaap:RetainedEarningsMember